Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US

Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US The company has launched the tablets in the strengths of 180 mg and 360 mg, Lupin said in a statement.

No comments:

Post a Comment